Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.
Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.
复制标题
9-β-D-阿拉伯呋喃糖基-2-氟腺嘌呤 5-单磷酸 (NSC 312887)（一种新型嘌呤抗代谢物）的 I 期临床研究。
作者：
Hutton,JJ;VonHoff,DD;Kuhn,J;Phillips,J;Hersh,M;Clark,G
